Announced Wed, 28 Oct, 2026 · 16:24 IST
GSK Pharma to hold analyst and investor meeting on 4 November 2026
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction
Awaiting price reaction for this filing.
AI summary
GSK Pharma has scheduled a group meeting with analysts and institutional investors for 4 November 2026. The meeting will be held digitally, and only information already in the public domain will be shared. The date may change if required.
Likely market impact
This is a routine investor-engagement notice with no new business or financial information, so the direct stock impact is likely neutral.